Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy

Journal of Clinical Investigation

Volumn 120, Issue 8, 2010, Pages 2672-2683

  Ojima, Koichi ^a,b,c   Kawabata, Yukiko ^b,d,e   Nakao, Harumi ^e,f   Nakao, Kazuki ^g   Doi, Naoko ^a,b   Kitamura, Fujiko ^a   Ono, Yasuko ^a,b   Hata, Shoji ^a   Suzuki, Hidenori ^h   Kawahara, Hiroyuki ⁱ   Bogomolovas, Julius ^j   Witt, Christian ^j   Ottenheijm, Coen ^k   Labeit, Siegfried ^j   Granzier, Henk ^k   Toyama Sorimachi, Noriko ^l   Sorimachi, Michiko ^m   Suzuki, Koichi ^n,o   Maeda, Tatsuya ^b,o   Abe, Keiko ^d   Aiba, Atsu ^b,e,f   Sorimachi, Hiroyuki ^a,b,d,o   more..

^a Calpain Project   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g RIKEN   (Japan)

^h TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

ⁱ TOKYO METROPOLITAN UNIVERSITY   (Japan)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k University of Arizona   (United States)

^l NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^m POLYTECHNIC UNIVERSITY   (Japan)

ⁿ TORAY INDUSTRIES INC   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CALPAIN 3; HEAT SHOCK PROTEIN; MUSCLE ANKYRIN REPEAT PROTEIN 2; UNCLASSIFIED DRUG;

ADAPTATION; ARTICLE; DYNAMICS; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXERCISE; GENETIC DISORDER; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2A; MOUSE; MUSCLE ATROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYSICAL STRESS; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR DYSTROPHY; PROTEIN FUNCTION; SARCOMERE; UPREGULATION;

ADAPTATION, PHYSIOLOGICAL; AGING; ANIMALS; CALPAIN; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MYOFIBRILS; NUCLEAR PROTEINS; PHYSICAL CONDITIONING, ANIMAL; REGENERATION; REPRESSOR PROTEINS; STRESS, MECHANICAL;

EID: 77955298542     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40658     Document Type: Article

References (45)

1. Tidball JG, Spencer MJ. Calpains and muscular dystrophies. Int J Biochem Cell Biol. 2000;32(1):1-5.
2. Richard I, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995;81(1):27-40.
3. Groen EJ, et al. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain. 2007;130(pt 12):3237-3249.
4. Nigro V. Molecular bases of autosomal recessive limb-girdle muscular dystrophies. Acta Myol. 2003;22(2):35-42.
5. Duguez S, Bartoli M, Richard I. Calpain 3: a key regulator of the sarcomere? FEBS J. 2006;273(15):3427-3436.
6. Leiden Muscular Dystrophy pages. Leiden Open Variation Database. http://www.dmd.nl/capn3-seqvar.html. Updated March 28, 2010. Accessed May 13, 2010.
7. Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004;53(suppl):S12-S18.
8. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83(3):731-801.
9. Richard I, et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64(6):1524-1540.
10. Saenz A, et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain. 2005;128(pt 4):732-742.
11. Piluso G, et al. Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet. 2005;42(9):686-693.
12. Tagawa K, et al. Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A. Hum Mol Genet. 2000;9(9):1393-1402.
13. Richard I, et al. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkBa/nuclear factor kB pathway perturbation in mice. J Cell Biol. 2000;151(7):1583-1590.
14. Kramerova I, Kudryashova E, Tidball JG, Spencer MJ. Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum Mol Genet. 2004;13(13):1373-1388.
15. Sorimachi H, et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem. 1995;270(52):31158-31162.
16. Granzier HL, Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res. 2004;94(3):284-295.
17. Hayashi C, et al. Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle. J Biol Chem. 2008;283(21):14801-14814.
18. Witt CC, et al. Induction and myofibrillar targeting of CARP, and suppression of the Nkx2.5 pathway in the MDM mouse with impaired titin-based signaling. J Mol Biol. 2004;336(1):145-154.
19. Ojima K, et al. Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain. J Biol Chem. 2007;282(19):14493-14504.
20. Murphy RM, Goodman CA, McKenna MJ, Bennie J, Leikis M, Lamb GD. Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J Appl Physiol. 2007;103(3):926-931.
21. McNeil PL, Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol. 1992;140(5):1097-1109.
22. Wang J, et al. Dynamics of Z-band based proteins in developing skeletal muscle cells. Cell Motil Cytoskeleton. 2005;61(1):34-48.
23. Tothova J, et al. NFATc1 nucleocytoplasmic shuttling is controlled by nerve activity in skeletal muscle. J Cell Sci. 2006;119(pt 8):1604-1611.
24. Puchner EM, et al. Mechanoenzymatics of titin kinase. Proc Natl Acad Sci U S A. 2008;105(36):13385-13390.
25. Ono Y, et al. Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J Biol Chem. 2006;281(27):18519- 18531.
26. Hentzen ER, et al. Stress-dependent and -independent expression of the myogenic regulatory factors and the MARP genes after eccentric contractions in rats. J Physiol. 2006;570(pt 1):157-167.
27. Lehti M, Kivela R, Komi P, Komulainen J, Kainulainen H, Kyrolainen H. Effects of fatiguing jumping exercise on mRNA expression of titin-complex proteins and calpains. J Appl Physiol. 2009;106(4):1419-1424.
28. Kojic S, et al. The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J Mol Biol. 2004;339(2):313-325.
29. Anderson LV, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 1999;8(5):855-861.
30. Ampong BN, Imamura M, Matsumiya T, Yoshida M, Takeda S. Intracellular localization of dysferlin and its association with the dihydropyridine receptor. Acta Myol. 2005;24(2):134-144.
31. Stockholm D, Bartoli M, Sillon G, Bourg N, Davoust J, Richard I. Imaging calpain protease activity by multiphoton FRET in living mice. J Mol Biol. 2005;346(1):215-222.
32. Diaz BG, Moldoveanu T, Kuiper MJ, Campbell RL, Davies PL. Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide. J Biol Chem. 2004;279(26):27656-27666.
33. 2+ dependent intramolecular autolysis. FEBS Lett. 2002;532(3):401-406.
34. Miller MK, et al. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol. 2003;333(5):951-964.
35. Pallavicini A, et al. Characterization of human skeletal muscle Ankrd2. Biochem Biophys Res Commun. 2001;285(2):378-386.
36. Bean C, Facchinello N, Faulkner G, Lanfranchi G. The effects of Ankrd2 alteration indicate its involvement in cell cycle regulation during muscle differentiation. Biochim Biophys Acta. 2008;1783(6):1023-1035.
37. Keira Y, Noguchi S, Minami N, Hayashi YK, Nishino I. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. J Biochem. 2003;133(5):659-664.
38. Shin JH, Kim HS, Lee CH, Kim CM, Park KH, Kim DS. Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy. J Korean Med Sci. 2007;22(3):463-469.
39. Sanger JM, Mittal B, Pochapin MB, Sanger JW. Myofibrillogenesis in living cells microinjected with fluorescently labeled alpha-actinin. J Cell Biol. 1986;102(6):2053-2066.
40. Takekura H, Fujinami N, Nishizawa T, Ogasawara H, Kasuga N. Eccentric exercise-induced morphological changes in the membrane systems involved in excitation-contraction coupling in rat skeletal muscle. J Physiol. 2001;533(pt 2):571-583.
41. Matsuda R, Nishikawa A, Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem. 1995;118(5):959-964.
42. Ojima K, et al. Mac-1(low) early myeloid cells in the bone marrow-derived SP fraction migrate into injured skeletal muscle and participate in muscle regeneration. Biochem Biophys Res Commun. 2004;321(4):1050-1061.
43. Sorimachi H, et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem. 1993;268(14):10593-10605.
44. Ono Y, et al. Comprehensive survey of p94/calpain 3 substrates by comparative proteomics-possible regulation of protein synthesis by p94. Biotechnol J. 2007;2(5):565-576.
45. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comp Graph Stat. 1996;(3):299-314.